NCT02723864 2022-02-08Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid TumorsNational Institutes of Health Clinical Center (CC)Phase 1 Completed53 enrolled 20 charts